See more : Trip.com Group Limited (9961.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Agronomics Limited (AGNMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Agronomics Limited, a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Asahi Yukizai Corporation (4216.T) Income Statement Analysis – Financial Results
- Scottish Mortgage Investment Trust PLC (SMT.L) Income Statement Analysis – Financial Results
- Fabege AB (publ) (FABG.ST) Income Statement Analysis – Financial Results
- Foxx Development Holdings Inc. (FOXX) Income Statement Analysis – Financial Results
- BRP Inc. (DOO.TO) Income Statement Analysis – Financial Results
Agronomics Limited (AGNMF)
About Agronomics Limited
Agronomics Limited is a principal investment firm specializing in investments in funds, equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, nascent industry of modern foods, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.70M | 440.32K | 260.10K | 1.28M | -11.56K | 20.82K | 62.18K | -317.84K | -190.78K | 2.10M | 588.97K | 510.52K |
| Cost of Revenue | 0.00 | -5.98M | -10.41M | 0.00 | 0.00 | 0.00 | 0.00 | -317.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 29.70M | 6.42M | 10.67M | 1.28M | -11.56K | 20.82K | 62.18K | 1.69 | -190.78K | 2.10M | 588.97K | 510.52K |
| Gross Profit Ratio | 100.00% | 1,458.90% | 4,102.20% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 18.98 | 3.92 | 0.00 | 25.00 | -10.15 | -0.60 | 1.68 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.98M | 5.68M | 8.08M | 615.75K | 199.91K | 191.23K | 218.13K | 209.89K | 434.56K | 600.95K | 168.28K | 30.34K |
| Selling & Marketing | 148.29K | 141.08K | 41.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.13K | 0.00 | 72.00 | 1.00K |
| SG&A | 4.13M | 5.82M | 8.08M | 615.75K | 199.91K | 191.23K | 218.13K | 209.89K | 439.69K | 600.95K | 168.35K | 31.34K |
| Other Expenses | 1.00M | 1.06M | 718.51K | 556.77K | -289.36K | 23.20M | 23.20M | 23.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.13M | 4.92M | 9.69M | 720.60K | 224.92K | 192.76K | 227.35K | 224.59K | 451.94K | 621.33K | 184.74K | 94.06K |
| Cost & Expenses | 5.13M | 4.92M | 9.69M | 720.60K | 224.92K | 192.76K | 227.35K | 224.59K | 451.94K | 621.33K | 184.74K | 94.06K |
| Interest Income | 1.17M | 344.02K | 149.66K | 60.56K | 12.02K | 16.67K | 9.97K | 31.00 | 122.00 | 0.00 | 8.69K | 2.46K |
| Interest Expense | 0.00 | 0.00 | 1.16K | 930.00 | 176.00 | 23.00 | 114.00 | 0.00 | 0.00 | 14.00 | 0.00 | 826.00 |
| Depreciation & Amortization | -8.00K | -22.45K | -2.46M | -555.83K | 301.09K | 228.01K | 47.14K | 538.45K | 340.61K | -2.10M | -1.16M | -6.30K |
| EBITDA | 24.56M | 1.50M | -9.43M | 0.00 | 0.00 | 0.00 | -166.17K | 209.55K | -261.16K | -715.13K | -757.41K | 416.45K |
| EBITDA Ratio | 82.70% | -2,576.84% | -7,828.16% | -107.80% | 1,288.72% | -756.72% | -655.66% | -29.35% | 136.90% | -34.07% | -128.60% | 81.58% |
| Operating Income | 24.57M | 11.10M | 9.74M | 551.17K | -300.94K | -228.08K | -47.00K | -534.40K | -601.77K | 1.38M | 406.47K | 422.75K |
| Operating Income Ratio | 82.73% | 2,520.44% | 3,745.97% | 43.15% | 2,604.20% | -1,095.59% | -75.59% | 168.13% | 315.43% | 65.82% | 69.01% | 82.81% |
| Total Other Income/Expenses | -2.20M | -2.74M | -8.72M | 60.56K | 12.02K | 16.67K | 9.97K | 31.00 | 122.00 | -14.00 | 8.69K | 2.46K |
| Income Before Tax | 22.37M | 8.36M | 1.02M | 611.73K | -288.92K | -211.41K | -37.03K | -534.37K | -601.65K | 1.38M | 415.16K | 425.21K |
| Income Before Tax Ratio | 75.32% | 1,898.24% | 392.09% | 47.89% | 2,500.16% | -1,015.50% | -59.55% | 168.12% | 315.37% | 65.81% | 70.49% | 83.29% |
| Income Tax Expense | 0.00 | 1.50M | 978.62K | 556.77K | -301.09K | -228.01K | -47.14K | -538.42K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 22.37M | 8.36M | 1.02M | 611.73K | -288.92K | -211.41K | -37.03K | -534.37K | -601.65K | 1.38M | 415.16K | 425.21K |
| Net Income Ratio | 75.32% | 1,898.24% | 392.09% | 47.89% | 2,500.16% | -1,015.50% | -59.55% | 168.12% | 315.37% | 65.81% | 70.49% | 83.29% |
| EPS | 0.02 | 0.01 | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | 0.04 | 0.01 | 0.02 |
| EPS Diluted | 0.02 | 0.01 | 0.00 | 0.01 | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | 0.04 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 984.86M | 877.49M | 468.46M | 92.15M | 23.20M | 23.20M | 23.20M | 23.20M | 29.64M | 33.86M | 33.21M | 23.43M |
| Weighted Avg Shares Out (Dil) | 1.02B | 914.68M | 796.65M | 92.15M | 23.20M | 23.20M | 23.20M | 23.20M | 29.64M | 33.86M | 33.21M | 23.43M |
Agronomics Limited Announces Net Asset Value Calculation as at 30 September 2024
DOUGLAS, ISLE OF MAN / ACCESSWIRE / November 28, 2024 / Agronomics Limited (AIM:ANIC), a leading listed company focused on the field of cellular agriculture, announces that its unaudited Net Asset Value ("NAV") calculation as at closing on 30 September...
Agronomics Limited Announces All G Co Update
All G Receives Approval for Sale of Recombinant Bovine Lactoferrin in China DOUGLAS, ISLE OF MAN / ACCESSWIRE / November 27, 2024 / Agronomics (LSE:ANIC), a leading listed company in the field of cellular agriculture, is delighted to announce that...
CORRECTION - Agronomics Invests US$ 2m in Liberation Labs
The following amendment has been made to the 'Agronomics invests US$ 2 million in Liberation Labs US$ 3.5 million fundraise and US Department of Defense US$ 1.39 million award' announcement released on 15 October 2024 at 07:00 with RNS number...
Agronomics Invests US$2M in Liberation Labs
Agronomics invests US$ 2 million in Liberation Labs US$ 3.5 million fundraise and US Department of Defense US$ 1.39 million award DOUGLAS, ISLE OF MAN / ACCESSWIRE / October 15, 2024 / AgronomicsLimited (LSE:ANIC), a leading listed company in the...
Agronomics Limited Announces Meatable awarded €7.6 million Innovation Credit
DOUGLAS, ISLE OF MAN / ACCESSWIRE / September 24, 2024 / Agronomics, a leading listed company in the field of cellular agriculture, is pleased to announce that its portfolio company, Meatable B.V. ("Meatable"), has secured €7.6 million in funding under...
Agronomics Limited Announces GALY Raises US$ 33 Million in Series B Financing
DOUGLAS, Isle of Man, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Agronomics Limited ("Agronomics" or the "Company")
Agronomics Limited Announces Onego Bio Secures EUR 14 million in New Funding
Onego Bio Secures EUR 14 million in New Funding DOUGLAS, ISLE OF MAN / ACCESSWIRE / July 18, 2024 / Agronomics (LSE:ANIC), a leading listed company in the field of cellular agriculture, is pleased to announce that its portfolio company,...
Meatly gains lab-grown pet food approval in world first
Cultivated meat, also known by its less-tantalising name of lab-grown meat, may not be approved for human consumption in the UK yet, but a recent regulatory approval could soon see it coming to a pet bowl near you. Start-up Meatly,...
Agronomics Limited Announces Exercise of Warrants & TVR
Exercise of Warrants Total Voting Rights DOUGLAS, ISLE OF MAN / ACCESSWIRE / June 6, 2024 / Agronomics Limited ("Agronomics" or the "Company") (AIM:ANIC), a leading listed company focused on the field of cellular agriculture, announces that pursuant to the...
Agronomics Limited Announces Meatly Unveils Protein-Free Medium
Portfolio Company Meatly Unveils Protein-Free Medium DOUGLAS, ISLE OF MAN / ACCESSWIRE / May 7, 2024 / Agronomics (LSE:ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company Good Dog Food...
Source: https://incomestatements.info
Category: Stock Reports